Shixia Wang - Concepedia

Author

Shixia Wang

University of Massachusetts Chan Medical School ORCID

Also Known As

Shi-xia Wang, Shixia Wang

184

Publications

5.6K

Citations

H-Index

Concepts

All Affiliations

University of Massachusetts Chan Medical School Nanjing Medical University New York University National Institute of Allergy and Infectious Diseases Jiangsu Province Hospital

About

Shixia Wang is an author at University of Massachusetts Chan Medical School specializing in medicine, immunology, and vaccination.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	37	71	3.4K
2	Allergy	13	17	642
3	Natural Sciences	3	3	190
4	Engineering	1	1	40
5	Public Health	1	1	60

Shixia Wang

103

Publications

4.6K

Citations

H-Index

Page 1

	Year	Citations
Identification of QS-21 as an Inflammasome-activating Molecular Component of Saponin Adjuvants Robyn Marty-Roix, Gregory I. Vladimer, Kimberly Pouliot, Journal of Biological Chemistry	2015	190
Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime–protein boost HIV-1 vaccine in healthy human volunteers Shixia Wang, Jeffrey S. Kennedy, Kim West, Vaccine VaccinationPolyvalent DnaHuman RetrovirusImmunodeficienciesImmunology	2008	181
Follicular regulatory T cells repress cytokine production by follicular helper T cells and optimize IgG responses in mice Hao Wu, Yuxin Chen, Hong Liu, European Journal of Immunology Lymphocyte DevelopmentAdaptive Immune SystemT-regulatory CellImmunologyImmunologic Mechanism	2016	156
The relative immunogenicity of DNA vaccines delivered by the intramuscular needle injection, electroporation and gene gun methods Shixia Wang, Chunghua Zhang, Lu Zhang, Vaccine VaccinologyVaccinationGene Gun MethodsIntramuscular Needle InjectionVaccine Development	2008	118
Polyvalent HIV-1 Env vaccine formulations delivered by the DNA priming plus protein boosting approach are effective in generating neutralizing antibodies against primary human immunodeficiency virus type 1 isolates from subtypes A, B, C, D and E Shixia Wang, Ranajit Pal, John R. Mascola, Virology VaccinationSubtypes AVaccine TargetHuman RetrovirusImmunology	2006	112
Relative contributions of codon usage, promoter efficiency and leader sequence to the antigen expression and immunogenicity of HIV-1 Env DNA vaccine Shixia Wang, Diego J. Farfán-Arribas, Siyuan Shen, Vaccine VaccinationCodon UsageLeader SequencePromoter EfficiencyNatural Sciences	2005	103
Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime–protein boost HIV-1 vaccine in healthy human volunteers Shixia Wang, Jeffrey S. Kennedy, Kim West, Vaccine VaccinationPolyvalent DnaHuman RetrovirusImmunodeficienciesImmunology	2008	101
Enhanced Immunogenicity of gp120 Protein When Combined with Recombinant DNA Priming To Generate Antibodies That Neutralize the JR-FL Primary Isolate of Human Immunodeficiency Virus Type 1 Shixia Wang, James Arthos, Jean M. Lawrence, Journal of Virology ImmunologyRecombinant DnaSubunit ProteinGp120 ProteinImmunotherapy	2005	100
Construction and Evaluation of a Safe, Live, Oral <i>Vibrio cholerae</i> Vaccine Candidate, IEM108 Weili Liang, Shixia Wang, Fenggang Yu, Infection and Immunity	2003	99
Immunization of rhesus macaques with a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 vaccine elicits protective antibody response against simian human immunodeficiency virus of R5 phenotype Ranajit Pal, Shixia Wang, V. S. Kalyanaraman, Virology VaccinationPolyvalent DnaVaccine DevelopmentRhesus MacaquesHuman Retrovirus	2006	94

Page 1